Luciole Pharmaceuticals, Inc

Luciole Pharmaceuticals, Inc. is a start-up biotechnology company based in Natick, MA, dedicated to discovering and developing small molecule activators of OGG1. Their innovative approach aims to accelerate the repair of oxidative damage to mitochondrial DNA, which plays a crucial role in providing energy to mammalian cells. By addressing mitochondrial dysfunction, oxidative stress, and inflammation, Luciole Pharmaceuticals aims to combat age-related diseases and neurodegenerative conditions associated with mitochondrial DNA damage.

With a focus on the upstream common link of mitochondrial DNA damage, Luciole Pharmaceuticals recognizes the role it plays in triggering inflammation and exacerbating oxidative stress and mitochondrial dysfunction. By targeting this key factor, the company aims to address the fragility and breakdown of mitochondrial DNA, ultimately working towards preventing cell death and improving overall mitochondrial function. Through their groundbreaking research, Luciole Pharmaceuticals is bringing energy to life and paving the way for advancements in the treatment of various age-related diseases.

Generated from the website